The short answer: A mother with breast cancer moves you out of the average-risk category in most US screening guidelines. NCCN says annual mammograms for increased risk may begin as early as age 30 and no later than 40. A common rule of thumb starts screening 10 years before your mother's age at diagnosis, but not before 30. Your exact plan depends on a calculated lifetime risk score, and 20 percent or more adds annual breast MRI.

Does your mother's diagnosis change your start age?

Usually, yes. A mother with breast cancer counts as first-degree family history. That places you in an increased-risk category, not the average-risk one.

The 2025 NCCN patient guideline gives two family-history triggers for increased risk: "a family history of cancer that suggests a genetic predisposition towards breast cancer," and "a strong family history that shows your lifetime risk is 20% or greater." For that group, annual mammogram screening "might begin as early as 30 years of age, but no later than 40 years of age." Annual breast MRI "might begin as early as 25 years of age, but no later than 40 years of age." Risk assessment itself should happen by age 25.

The American College of Radiology sets the same deadline. Its 2023 higher-than-average-risk recommendations say all women "should undergo risk assessment by age 25, especially Black women and women of Ashkenazi Jewish heritage."

The USPSTF is the outlier. Its 2024 recommendation covers people "who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer)." So it keeps a simple maternal history inside the biennial 40 to 74 schedule. It steps aside only for known BRCA variants, prior high-dose chest radiation, or a previous breast cancer or high-risk lesion. Our guide to first-mammogram timing covers the average-risk debate.

What is the 10-years-before rule?

This is the number most people hear first. A 2024 comparative review of screening guidelines in Diagnostics records the NCCN wording for lifetime risk above 20 percent from family history. It calls for annual mammography "beginning 10 years prior to when the youngest family member was diagnosed with breast cancer, not prior to age 30, or begin at age 40 (whichever comes first)." Annual MRI runs on the same clock, with a floor of 25 instead of 30.

Two examples show how the floors and ceilings work:

  • Your mother was diagnosed at 45. Ten years earlier is 35, which is above the age 30 floor. You would start mammograms around 35.
  • Your mother was diagnosed at 62. Ten years earlier is 52, which is past 40. The rule never delays you, so you start at 40.

The rule is common, but its evidence base is thin. A Breast Cancer Surveillance Consortium analysis of 74,838 first screening mammograms, published in Cancer Causes and Control, notes that "the origin of this recommendation is unknown." The authors add: "There is no direct evidence of the effectiveness of earlier mammography screening in the absence of genetic mutations." In their data, 48 percent of women with a first-degree family history started before 40, against 23 percent of women without one.

How much does a mother's diagnosis raise your risk?

The best estimate comes from a pooled reanalysis of 52 studies in The Lancet, covering 58,209 women with breast cancer and 101,986 without. Against women with no affected relative, the risk ratios were:

  • 1.80 (99% CI 1.69 to 1.91) with one affected first-degree relative.
  • 2.93 (2.36 to 3.64) with two.
  • 3.90 (2.03 to 7.49) with three or more.

In plain risk, cumulative incidence up to age 80 was 7.8 percent with no affected first-degree relative, 13.3 percent with one, and 21.1 percent with two. Results "did not differ substantially between women reporting an affected mother (9104) or sister (6386)." The American Cancer Society says it more simply: one first-degree relative "almost doubles a woman's risk," and two "can triple the risk."

Second-degree relatives (a grandmother, aunt, niece, or half-sister) still count, but carry less weight than a mother. The practical issue is which calculator captures them.

Which risk model decides your number?

NCCN names the accepted tools: "BRCAPRO, Tyrer-Cuzick, BOADICEA/CanRisk, or BCSC." Each returns a residual lifetime risk percentage. Twenty percent is the threshold that changes your plan.

The models are not interchangeable. The Gail model, published by NCI as the Breast Cancer Risk Assessment Tool, uses "the history of breast cancer among her first-degree relatives (mother, sisters, daughters)." NCI warns it cannot accurately estimate risk for "women carrying a breast-cancer-associated mutation in BRCA1 or BRCA2." A study in Breast Cancer Research and Treatment spells out the gap: Gail "considers only first-degree family history of the disease and does not include paternal history of breast cancer or male breast cancer, history of ovarian cancer and age at cancer diagnosis." Its conclusion: "In women with a familial history of cancer, the Gail model underestimates risk and the Tyrer-Cuzick seems to be more appropriate."

Tyrer-Cuzick (the IBIS model) and BOADICEA/CanRisk read a full pedigree: second-degree relatives, paternal history, ovarian cancer, and each relative's age at diagnosis. Ask which model produced your number. It can decide whether you qualify for MRI.

When do you add breast MRI or genetic testing?

Supplemental MRI is threshold-driven. The American Cancer Society recommends annual breast MRI plus mammogram, typically starting at age 30, for women with "a lifetime risk of breast cancer of about 20% to 25% or greater, according to risk assessment tools that are based mainly on family history." It recommends against MRI below 15 percent and calls the evidence insufficient between 15 and 20 percent. ACS also treats a first-degree relative with a known BRCA1 or BRCA2 change as high risk, even if you have not been tested.

The ACR puts MRI surveillance at ages 25 to 30 for genetics-based risk or a lifetime risk of 20 percent or more. Dense tissue is a separate NCCN increased-risk category, so it can stack with family history; see dense breasts explained. Our comparison of breast MRI versus mammography explains what each test finds, and mri.md covers how the scan works.

Genetic counseling has its own trigger. The USPSTF gives a Grade B recommendation that clinicians "assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer" using a brief familial risk assessment tool, then refer for counseling and testing if the screen is positive. Patterns that prompt assessment include diagnosis before age 50, bilateral breast cancer, breast and ovarian cancer in one person, male relatives with breast cancer, multiple affected relatives, and Ashkenazi Jewish ancestry.

Does your mother's age at diagnosis matter?

It matters in two ways. The Lancet reanalysis found risk ratios "were greatest at young ages, and for women of a given age, were greater the younger the relative was when diagnosed." The American Cancer Society puts a number on the extreme case: one first-degree relative diagnosed before age 30 triples your risk.

A premenopausal maternal diagnosis, roughly before 50, also raises the chance an inherited variant runs in the family. That is why the USPSTF list uses age 50 as a counseling trigger, and why the 10-years-before rule bites hardest here. A mother diagnosed at 42 pulls your first mammogram to 32. A mother diagnosed at 68 leaves you starting at 40.

One caveat keeps this in proportion. The Lancet authors reported that the relative's age at diagnosis "had only a moderate effect" on absolute lifetime estimates. They also found that eight of nine women who develop breast cancer have no affected mother, sister, or daughter.

The bottom line

With a mother who had breast cancer, expect to start mammograms before 40. NCCN puts the window at 30 to 40 for increased risk, and the common rule of thumb is 10 years before your mother's diagnosis age, with a floor of 30. Get a formal risk assessment by 25 using a full-pedigree model such as Tyrer-Cuzick or BOADICEA/CanRisk, not Gail alone. A lifetime risk of 20 percent or more adds annual breast MRI. Ask about genetic counseling if your mother was diagnosed before 50, had cancer in both breasts, or if other relatives were affected.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Bring your full family cancer history, with ages at diagnosis on both sides, to your clinician.